🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2024-03-14
Trial ID
NCT05813327
Treatments Being Tested
To find the best dose of ADI-PEG20 that can be given in combination with ca...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-02-29
Trial ID
NCT06085729
Treatments Being Tested
Amino acid deprivation therapy is an effective means for the treatment of s...
Status
Completed
Location
MD Anderson Cancer center
Start Date
2002-09
Trial ID
NCT00056992
Treatments Being Tested
This is a phase 1b, open label trial of ADI-PEG 20 (36 mg/m2) weekly in com...
Status
Terminated
Location
Facility National Cheng Kung University
Start Date
2017-07-14
Trial ID
NCT03254732
Treatments Being Tested
Assessment of safety and tolerability of drug combination and determine tim...
Status
Terminated
Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start Date
2017-01-20
Trial ID
NCT02875093
Treatments Being Tested
Evaluate efficacy and safety of ADI-PEG 20 in patients with NASH...
Status
Recruiting
Location
Ditmanson Medical Foundation Chiayi Christian Hospital；Chiayi Christian Hospital (CYCH)
Start Date
2023-09-13
Trial ID
NCT05842512
The investigators have recently demonstrated that argininosuccinate synthas...
Status
Completed
Location
Stanford Medicine
Start Date
2018-05-09
Trial ID
NCT03449901
Treatments Being Tested
This was a phase 1/2, open-label, dose-escalation study of arginine deimina...
Status
Completed
Location
NYU Cancer Institute
Start Date
2007-07
Trial ID
NCT00520299
Treatments Being Tested
To examine whether the arginine depleting drug, ADI-PEG 20, might be effect...
Status
Unknown
Location
The Royal Sussex County Hospital
Start Date
2011-01
Trial ID
NCT01279967
Treatments Being Tested
To learn about the safety and tolerability of atezolizumab, bevacizumab, an...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2023-08-08
Trial ID
NCT06006286
Treatments Being Tested